The University of Arizona Health Sciences Center for Advanced Molecular and Immunological Therapies, or CAMI, received a strong vote of support from Arizona Gov. Doug Ducey, who designated $150 million in new funding for the Phoenix-based center. At the same time, CAMI received its first private philanthropic support as part of a new $10 million gift from the Steele Foundation.
Tag: UArizona
New UArizona Center for Advanced Molecular and Immunological Therapies to drive significant economic impact to Phoenix
The new University of Arizona Center for Advanced and Molecular and Immunological Therapies, which will be located on the Phoenix Bioscience Core, is expected to have an economic impact of as high as $4.8 billion and attract more than 150 companies to Phoenix, according to a new study.
UArizona Health Sciences previews new Center for Advanced Molecular and Immunological Therapies in Phoenix
The University of Arizona offered a new preview of the Center for Advanced Molecular and Immunological Therapies on May 16 as part of its Tomorrow is Here lecture series. The […]
UArizona College of Medicine – Phoenix’s Ayman Fanous contributes to largest worldwide study of Schizophrenia
In a paper published April 8 in Nature, specific genes were identified that could play important roles in the psychiatric disorder. In the largest genetic study of schizophrenia, researchers including Ayman Fanous, MD, analyzed DNA from 76,755 people with schizophrenia and 243,649 without it to better understand the genes and biological processes underpinning the condition.
Catheter-based cardioneural ablation safe, effective for recurrent fainting, according to UArizona COM-P report
e by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.
Connecting with UArizona College of Medicine – Phoenix Dean Guy Reed
The University of Arizona Health Sciences spoke to UArizona College of Medicine – Phoenix Dean Guy Reed at the end of the academic year to discuss the past two years, what lies ahead for the College of Medicine – Phoenix and the Phoenix Bioscience Core.
Arizona COVID-19 Genomics Union compile 100,000 sequenced genomes of COVID-19
The Arizona COVID-19 Genomics Union, which includes PBC institutions such as Arizona State University, Northern Arizona University, the Translational Genomics Research Institute and the University of Arizona have successfully compiled 100,000 sequenced genomes of COVID-19 to combat the next pandemic.
7th Annual ABRC-Flinn Research Conference highlights wide range of translational research
Translational research in pancreatic and chronic lung diseases, opioid receptors, West Nile Virus, Rocky Mountain Spotted Fever transmission, autism in older adults and insulin-dependent diabetes were among the topics discussed at the 7th ABRC-Flinn Research Conference.
Flinn Foundation commits $5.52 million to UArizona College of Medicine – Phoenix
The University of Arizona College of Medicine – Phoenix announced April 7 the Flinn Foundation has awarded the college $5.52 million to establish research faculty positions on the Phoenix Bioscience Core and support training to further translational research in cardiovascular diseases, neurosciences and mental health.
UArizona selects Phoenix Bioscience Core as site of new Center for Advanced Molecular and Immunological Therapies
The University of Arizona announced April 6 that the Phoenix Bioscience Core will be the site of the new UArizona Center for Advanced Molecular and Immunological Therapies.